Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-04

Clinical Trial Update: Peripheral Blood Autologous CD34+ Cell Transplantation Promotes Angiogenesis With Atherosclerotic Ischemia for Elderly [NA]

View source ↗

Summary

This clinical trial update discusses autologous peripheral blood CD34+ cell transplantation aimed at promoting angiogenesis in elderly patients with atheroscler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peripheral blood autologous CD34+ cell transplantation (CD34+ cell transplantation (autologous, peripheral blood))

Snippet

Sponsor: Qingdao University | Conditions: Atherosclerotic Ischemic Disease | NA | Status: UNKNOWN